Primary information |
---|
PRRID | PRRID_2160 |
Ligand Name | Histone |
Source | Nucleus (others) |
Sequence of ligand | NA |
Length | NA |
Type | Damage-associated molecular patterns (DAMPs) |
Occurence | Natural |
Role of Ligand | nvolved in the resolution and fine-tuning of inflammation by orchestrating the production of anti-inflammatory mediators that are required for the resolution of tissue inflammation and the transition to acquired immunity |
Name of receptor | Nod-like receptor P3 (NLRP3) |
Type of receptor | NOD-like receptor (NLR) |
Source | NA |
Localization | NA |
Domain | NA |
Sequence of Receptor | NA |
Swiss prot ID | NA |
Length Of Receptor | NA |
Function | NA |
Assay used | NA |
PMID | 29290139 |
Year of Publication | 2017 |
Pubchem assay | NA |
Primary information |
---|
PRRID | PRRID_2160 |
Ligand Name | Histone |
Source | Nucleus (others) |
Sequence of ligand | NA |
Length | NA |
Type | Damage-associated molecular patterns (DAMPs) |
Occurence | Natural |
Role of Ligand | nvolved in the resolution and fine-tuning of inflammation by orchestrating the production of anti-inflammatory mediators that are required for the resolution of tissue inflammation and the transition to acquired immunity |
Name of receptor | Nod-like receptor P3 (NLRP3) |
Type of receptor | NOD-like receptor (NLR) |
Source | NA |
Localization | NA |
Domain | NA |
Sequence of Receptor | NA |
Swiss prot ID | NA |
Length Of Receptor | NA |
Function | NA |
Assay used | NA |
PMID | 29290139 |
Year of Publication | 2017 |
Pubchem assay | NA |